T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.52B |
| 2 |
Boeing
BA
|
+$1.89B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 4 |
Amphenol
APH
|
+$1.1B |
| 5 |
CME Group
CME
|
+$911M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.87B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.1B |
| 3 |
UnitedHealth
UNH
|
+$1.83B |
| 4 |
Uber
UBER
|
+$1.56B |
| 5 |
Adobe
ADBE
|
+$1.29B |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.14% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Incyte
INCY
$16.8B
| $63.1M | 0.01% |
913,708
+305,264
| +50% | +$21.1M |
|
677
Wave Life Sciences
WVE
$1.18B
| $63.1M | 0.01% |
5,098,866
+1,972,262
| +63% | +$24.4M |
|
678
Eagle Materials
EXP
$7.49B
| $62.9M | 0.01% |
254,868
-588
| -0.2% | -$145K |
|
679
FTAI Aviation
FTAI
$17.2B
| $62.9M | 0.01% |
436,517
-501,928
| -53% | -$72.3M |
|
680
Lennox International
LII
$19.6B
| $62.8M | 0.01% |
103,042
+29,579
| +40% | +$18M |
|
681
Comfort Systems
FIX
$26.5B
| $62.7M | 0.01% |
147,789
-14,144
| -9% | -$6M |
|
682
XPO
XPO
$15.3B
| $62.6M | 0.01% |
477,349
-23,609
| -5% | -$3.1M |
|
683
Colliers International
CIGI
$8.4B
| $62.4M | 0.01% |
458,569
+4,101
| +0.9% | +$558K |
|
684
Fidelity National Information Services
FIS
$34.7B
| $62.3M | 0.01% |
771,783
+3,938
| +0.5% | +$318K |
|
685
Denali Therapeutics
DNLI
$2.14B
| $62.3M | 0.01% |
3,058,615
+188,820
| +7% | +$3.85M |
|
686
ATI
ATI
$10.5B
| $62.1M | 0.01% |
1,128,962
+5,663
| +0.5% | +$312K |
|
687
TKO Group
TKO
$16B
| $62.1M | 0.01% |
436,826
+13,232
| +3% | +$1.88M |
|
688
Zai Lab
ZLAB
$3.16B
| $61.7M | 0.01% |
2,354,025
+548,378
| +30% | +$14.4M |
|
689
HEICO
HEI
$44.1B
| $61.4M | 0.01% |
258,390
+33,162
| +15% | +$7.88M |
|
690
NRG Energy
NRG
$31.2B
| $61.2M | 0.01% |
677,894
+368,473
| +119% | +$33.2M |
|
691
Pliant Therapeutics
PLRX
$104M
| $61M | 0.01% |
4,634,486
-200,327
| -4% | -$2.64M |
|
692
Performance Food Group
PFGC
$16.3B
| $61M | 0.01% |
721,853
-73,958
| -9% | -$6.25M |
|
693
Prudential Financial
PRU
$37.2B
| $61M | 0.01% |
514,702
+6,669
| +1% | +$790K |
|
694
T. Rowe Price Dividend Growth ETF
TDVG
$1.07B
| $60.4M | 0.01% |
1,525,001
+400,000
| +36% | +$15.8M |
|
695
Axalta
AXTA
$6.7B
| $60.4M | 0.01% |
1,763,973
+198,551
| +13% | +$6.79M |
|
696
Public Service Enterprise Group
PEG
$40.8B
| $60.3M | 0.01% |
713,684
+12,843
| +2% | +$1.09M |
|
697
Agnico Eagle Mines
AEM
$76.8B
| $60.2M | 0.01% |
770,178
-896,305
| -54% | -$70.1M |
|
698
Emcor
EME
$28.4B
| $60.2M | 0.01% |
132,541
-7,947
| -6% | -$3.61M |
|
699
Janux Therapeutics
JANX
$1.46B
| $59.4M | 0.01% |
1,109,978
+950,557
| +596% | +$50.9M |
|
700
AngloGold Ashanti
AU
$32.6B
| $59.3M | 0.01% |
2,569,868
+1,045,335
| +69% | +$24.1M |
|